日本語View as Markdown

Protection of the retina by rapid diffusion of hydrogen: administration of hydrogen-loaded eye drops in retinal ischemia-reperfusion injury.

水素含有点眼液による網膜虚血再灌流傷害への神経保護効果:ラットモデルを用いた検討

animal study topical application positive

Abstract

Using a rat model of retinal ischemia-reperfusion (I/R) injury induced by transient intraocular pressure elevation, hydrogen-saturated saline eye drops were applied continuously to the ocular surface during ischemia and reperfusion phases. Vitreous hydrogen concentration rose rapidly after administration, accompanied by a reduction in hydroxyl radical levels. Quantification one day post-injury showed decreased apoptotic cell counts and fewer cells positive for oxidative stress markers (4-hydroxynonenal and 8-hydroxy-2-deoxyguanosine). Seven days after injury, retinal thickness recovery exceeded 70% compared to untreated controls, and activation of Müller glia, astrocytes, and microglia was observed. These findings indicate that topically applied hydrogen-rich drops can rapidly diffuse into ocular tissues and confer neuroprotective and antioxidative effects in acute retinal I/R injury.

Mechanism

Hydrogen diffuses rapidly from the ocular surface into the vitreous, where it selectively scavenges hydroxyl radicals, reducing oxidative stress markers and suppressing apoptosis in retinal neurons following ischemia-reperfusion injury.

Bibliographic

Authors
Oharazawa H, Igarashi T, Yokota T, Fujii H, Suzuki H, Machide M, et al.
Journal
Invest Ophthalmol Vis Sci
Year
2010
PMID
19834032
DOI
10.1167/iovs.09-4089

Tags

Disease:虚血再灌流障害 網膜疾患 Delivery:局所投与 Mechanism:アポトーシス抑制 ヒドロキシルラジカル消去 酸化ストレス 活性酸素種

Delivery context

Topical applications have localized-effect reports, but systemic hydrogen intake is most efficient via inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

Topical applications have localized-effect reports, but systemic hydrogen intake is most efficient via inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 19834032. https://h2-papers.org/en/papers/19834032
Source: PubMed PMID 19834032